Keywords: arqule, begins, enrollment, phase, ii, clinical, trial

ArQule begins enrollment in a Phase II clinical trial of ARQ

Article | 10 July 2006

Print This

USA-based biotechnology company ArQule, a specialist in small-molecule therapeutics, says that it has begun enrollment in a Phase II clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in